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Abstract
The regulation of inflammation is pivotal for preventing the devel-
opment or reoccurrence of multiple sclerosis (MS). A biased ratio of
high-M1 versus low-M2 polarized microglia is a major pathological
feature of MS. Here, using microarray screening, we identify the long
noncoding RNA (lncRNA) GAS5 as an epigenetic regulator of micro-
glial polarization. Gain- and loss-of-function studies reveal that
GAS5 suppresses microglial M2 polarization. Interference with GAS5
in transplanted microglia attenuates the progression of experimen-
tal autoimmune encephalomyelitis (EAE) and promotes remyelina-
tion in a lysolecithin-induced demyelination model. In agreement,
higher levels of GAS5 are found in amoeboid-shaped microglia in MS
patients. Further, functional studies demonstrate that GAS5
suppresses transcription of TRF4, a key factor controlling M2 macro-
phage polarization, by recruiting the polycomb repressive complex 2
(PRC2), thereby inhibiting M2 polarization. Thus, GAS5 may be a
promising target for the treatment of demyelinating diseases.
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Introduction
Multiple sclerosis (MS) is a multifocal, inflammatory demyelinating
disease of the central nervous system (CNS). In the early stages, clini-
cal signs appear in a relapsing–remitting pattern, but in the later stage,
the disease develops into a secondary progressive phase without
remission [1]. Currently, no effective treatment is available for progres-
sive MS, and new therapeutic strategies are greatly needed [2,3].
Multiple sclerosis is an autoimmune disease with a significant
neurodegenerative component [4,5]. As the major innate immune cells
in the CNS, microglia play a central role in the inflammatory process
of MS and in the disruption of neuronal elements within the CNS.
Activated microglia can be classified into two functional subtypes:
M1/classic and M2/alternative polarization [6]. Although such a clas-
sification underestimates the complexity of macrophage/microglia
plasticity, the distinction nevertheless provides a useful framework for
exploring the diverse functions of the innate immune system in
disease pathogenesis. M1 polarized microglia promote neuronal apop-
tosis and inhibit oligodendrocyte progenitor cell (OPC) differentiation
into mature oligodendrocytes (OLs), whereas M2 polarized microglia
promote neuronal survival, neurite outgrowth, and OPC differentiation
[7–10]. In experimental autoimmune encephalomyelitis (EAE), animal
model of MS, inhibiting the secretion of inflammatory factors from
microglia significantly, reduces the EAE severity, whereas transplant-
ing M2 polarized microglia into the CNS promotes recovery [11–13].
In MS patients, M1 microglia were present in a variety of lesions,
whereas M2 microglia appear only in acute lesions and the active
edges of chronic active lesions where remyelination often occurs [9].
A delay in the transition to an M2 dominant environment is associated
with the slowing of remyelination in aging [9,14]. Thus, microglial
polarization is closely related to MS pathogenesis.
Long noncoding RNAs (lncRNAs) are a class of RNAs greater
than 200 bp in length with no protein-coding capacity. Increasing
evidence has shown that lncRNAs are involved in multiple biologi-
cal processes including CNS disease [15,16]. However, no lncRNAs
have been reported to play a role in the regulation of microglia and
MS pathogenesis.
In the present study, more than one hundred lncRNAs were iden-
tified to be differentially expressed in M2 polarized microglia versus
resting microglia through microarray screening. Among these
lncRNAs, was the lncRNA growth arrest-specific 5 (GAS5), origi-
nally identified in growth-arrested cells and which encodes no func-
tional protein but the introns encode a variety of functional small
noncoding nucleolar RNAs (snoRNAs) [17]. GAS5 inhibits the
proliferation of T cells and promotes tumor cell apoptosis [18–20].
In this study, we found that GAS5 suppressed IRF4 transcription by
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binding PRC2 to inhibit M2 polarization. GAS5 was shown to be
involved in the regulation of EAE progression. Moreover, GAS5
inhibited human microglial M2 polarization and was highly
expressed in the amoeboid-shaped microglia in MS lesions, suggest-
ing a novel role for an lncRNA in MS pathogenesis.
Results
GAS5 expression is decreased in M2 polarized microglia
To find potential lncRNAs participating in the regulation of micro-
glial polarization, we employed microarray screening. A total of 120
lncRNAs were differentially expressed (greater than twofold;
P < 0.05) in IL-4-stimulated M2 microglia versus resting microglia
(Fig 1A). Among them, GAS5 was significantly decreased in the M2
polarized microglia and was closely related with other differentially
expressed molecules, including known macrophage polarization
regulators such as TSC1 [21] (Fig 1B). This information prompted
us to examine whether GAS5 is involved in the regulation of micro-
glia polarization. First, we validated microarray results by qPCR and
the results showed GAS5 was dramatically decreased in IL-4 stimu-
lated primary cultured microglia (Fig 1C). We also examined the
GAS5 level during microglial polarization induced by other factors.
Macrophage colony-stimulating factor (M-CSF) has been reported
to promote M2 polarization [22]. Consistent with the induction by
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Figure 1. GAS5 is downregulated in M2-polarized microglia.
A Hierarchical clustering analysis of 120 lncRNAs that were differentially expressed between microglia treated with IL-4 for 24 h and the untreated control (greater
than twofold; P < 0.05). Expression values are represented in shades of red and green and indicate expression above and below the median expression value across
all samples (log scale 2, from 3 to 3), respectively.
B Co-expression network in IL-4-stimulated microglia. The co-expression network includes 1,627 connections among 319 genes that are correlated at |r| > 0.99. The
color of the nodes is in accordance with the K-core number shown in the legend. Real lines between two nodes indicate positively correlated interactions between
genes, and dashed lines indicate negatively correlated interactions. The enlarged box shows that GAS5 is a key in the network.
C Quantitative PCR analysis of GAS5 in microglia treated with IL-4 for 24 h versus the untreated control, n = 3 experiments.
D Quantitative PCR analysis of GAS5 in M-CSF-treated microglia versus the untreated control, n = 3 experiments.
E Quantitative PCR analysis of GAS5 in rapamycin-treated microglia versus the untreated control, n = 3 experiments.
F Quantitative PCR analysis of GAS5 in LY294002-treated microglia versus the untreated control, n = 3 experiments.
Data information: *P < 0.05, **P < 0.01, ***P < 0.001 (Student’s t-test). Data are shown as the mean  SD.
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IL-4, we found that GAS5 was greatly decreased in M-CSF-stimu-
lated primary cultured microglia (Fig 1D). Because rapamycin
(mTOR inhibitor) has been shown to inhibit M2 polarization [23],
we applied rapamycin to the cultured microglia and found that the
GAS5 expression level was significantly increased (Fig 1E). The
PI3K inhibitor LY294002, which also inhibits M2 polarization,
showed a similar result (Fig 1F). These results indicate an inverse
correlation between GAS5 expression and M2 polarization.
GAS5 suppresses microglial M2 polarization and promotes
M1 polarization
To investigate whether GAS5 directly regulated microglial
polarization, we transfected primary cultured microglia with GAS5
overexpression (GAS5OE) or GAS5 interference (GAS5i) lentiviral
vectors. qPCR analysis showed that GAS5 overexpression in microglia
decreased the expression of the M2 markers Ym-1, Fizz-1, CD206, and
IGF-1 and increased the expression of the M1 markers TNF-a and IL-
1b (Fig 2A). Conversely, interference with GAS5 in microglia resulted
in an increase in the expression of M2 markers and a decrease in the
expression of M1 markers (Fig 2B, Appendix Fig S1A). ELISA and
Western blotting showed similar changes in TNF-a, IL-1b, and
IGF-1 protein expression in the supernatants or protein lysates
from the microglia overexpressing GAS5 (MGGAS5OE; Fig 2C and E)
or the microglia with GAS5 interference (MGGAS5i; Fig 2D and F).
Overexpression or interference with GAS5 in peripheral monocytes
resulted in a similar phenotype (Fig EV5C and D). Besides, to test
the influence of GAS5 on the secretion of cytokines by microglia,
we conducted co-culture experiments using the conditioned
medium from GAS5-modified microglia in vitro and found OPC
survival, and differentiation and neurite growth were significantly
impaired in the GAS5OE group (Figs EV1 and EV2). These results
indicate that GAS5 suppresses microglial M2 polarization and
promotes M1 polarization.
GAS5 expression in microglia during EAE
To elucidate the role of GAS5 in microglial functions in vivo, we
induced EAE in C57BL/6 mice. First, we observed the GAS5
expression pattern in spinal cord sections from EAE mice 20 days
post-immunization (20 dpi) by FISH. As shown in Fig 3A, GAS5 was
expressed in Iba1+ cells (microglia and infiltrating macrophages) and
especially in the amoeba-shaped microglia/macrophages, which
tended to be M1 polarized [24]. The ramification index is often
used to quantitatively analyze the morphology of microglia/
macrophages [25,26]. We found that the ramification index of
GAS5+ microglia/macrophages was significantly higher than the
index in GAS5 cells (Fig 3C). The same went for TMEM119+
microglia (Fig EV3). Further analysis revealed that more GAS5 was
expressed in TNF-a+ (M1 marker) cells than Arg-1+ (M2 marker)
cells (Fig 3E and F).
To quantify GAS5 expression in microglia during EAE, we
isolated microglia from mice in the control group, during the peak
stage of EAE (15 dpi) and during the chronic stage of EAE (40 dpi)
(Fig 3G). The qPCR showed that the GAS5 level was higher in the
EAE mice than the controls. The expression reached its highest
point during the peak stage of EAE when inflammation was promi-
nent (Fig 3H).
GAS5-modified microglia regulate EAE progression
To elucidate the role of GAS5 in microglial functions in vivo, we
used the adoptive transfer strategy and transplanted GAS5-modified
microglia into the cerebral ventricles of EAE mice at 8 dpi. The
results showed that the transplantation of MGGAS5OE exacerbated
EAE (Fig 4A), whereas MGGAS5i alleviated EAE (Fig 4B). Moreover,
H&E staining showed that the infiltration of inflammatory cells into
the lumbar spinal cord of the EAE mice at 20 dpi was increased
after MGGAS5OE transplantation and reduced after MGGAS5i trans-
plantation (Fig 4C and D). Luxol fast blue (LFB) staining showed
exacerbated myelin loss in the white matter after MGGAS5OE trans-
plantation and attenuated myelin loss after MGGAS5i transplanta-
tion (Fig 4E and F).
The in vitro co-culture experiments and the in vivo transplanta-
tion work both showed protective effects of GAS5 interference in
microglia. Next, we examined the effect of MGGAS5i application
after EAE onset. MGGAS5i was transplanted into the cerebral ventri-
cle of EAE mice at 20 dpi, and the lumbar spinal cord was
collected at 40 dpi for histological analysis. A recovery in the EAE
scores was detected after MGGAS5i transplantation (Fig 5A), with
reduced inflammatory infiltrating cells (Fig 5B and D) and allevi-
ated demyelination (Fig 5C and E). These results demonstrated
that interfering with GAS5 in microglia was beneficial for EAE
treatment.
GAS5 interference in microglia promotes remyelination following
lysolecithin-induced focal demyelination
Inflammation-induced demyelination is the core pathological feature
of EAE. To avoid the influence of microglial transplantation on the
immune reaction, we applied MGGAS5i in the lysolecithin-induced
focal demyelination model to evaluate the effects on demyelination
and remyelination. Focal demyelination was induced by injecting
lysolecithin into the dorsal spinal cord white matter, and MGGAS5i
was transplanted 3 days post-lysolecithin injection (dpl). The spinal
cords around the injection points were isolated at 7, 11, and 15 dpl
and subjected to LFB or immunohistofluorescence (IHF) staining.
LFB staining showed increased remyelination at 11 and 15 dpl after
MGGAS5i transplantation (Fig 6A and B). IHF staining further illus-
trated that more Olig2+ oligodendrocyte lineage cells were accumu-
lated in the lesion of MGGAS5i-transplanted mice even at 7 dpl
(Fig 6C and D). More significantly, CC1+ cells (differentiated oligo-
dendrocytes) were also increased within lesions in MGGAS5i-trans-
planted animals at 7, 11, and 15 dpl (Fig 6C and E). Electron
microscopy (EM) analysis revealed a higher percentage of remyeli-
nated axons and a lower g-ratio within lesions after MGGAS5i trans-
plantation at 15 dpl (Fig 6F–I), suggesting that interfering with
GAS5 in microglia promoted remyelination.
GAS5 suppresses IRF4 transcription by binding PRC2 and
inhibiting microglial M2 polarization
To explore the mechanisms underlying the effect of GAS5 on micro-
glia, we first conducted an RNA pull-down followed by silver stain-
ing after SDS–PAGE gel electrophoresis to identify proteins that
specifically bound to GAS5. After incubation with the microglial
protein lysate, no specific bands between the GAS5 mRNA and the
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antisense control were detected by silver staining (Fig EV4A). GAS5
was reported to bind to the glucocorticoid receptor [27], but our
RNA immunoprecipitation study showed that only a very small
portion of GAS5 bound with this receptor (Fig EV4B), consistent
with the report that the binding requires the addition of glucocorti-
coids [28]. Therefore, it is unlikely that GAS5 regulates microglial
polarization through glucocorticoid receptor signaling. Previous
work showed that recruiting polycomb repressive complex 2 (PRC2)
to the promoter region of target genes repressed transcription and
was an important mechanism for long intergenic noncoding RNAs
(lincRNAs) [15]. To test whether the lincRNA GAS5 interacted with
PRC2, we performed an RNA immunoprecipitation assay with an
C D
E F
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Figure 2. GAS5 suppresses microglial M2 polarization and promotes M1 polarization.
A, B Quantitative PCR analysis of M1 and M2 markers in microglia transduced with the GAS5OE (A) or GAS5i (B) lentivirus vectors versus the control, n ≥ 3 experiments.
C, D ELISA analysis of TNF-a, IL-1b, and IGF-1 in culture supernatants of microglia transduced with the GAS5OE (C) or GAS5i (D) lentivirus vectors versus the control,
n ≥ 3 experiments.
E, F Western blotting analysis of TNF-a in microglia transduced with the GAS5OE (E) or GAS5i (F) lentivirus vectors versus the control, n ≥ 3 experiments.
Data information: *P < 0.05, ***P < 0.001 versus control (Student’s t-test). Data are shown as the mean  SD.
Source data are available online for this figure.
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Figure 3. GAS5 is dynamically expressed in the microglia of EAE.
A Representative FISH analysis of GAS5 (green) co-stained with an anti-Iba1 antibody (red) in spinal cord sections from EAE mice. Arrows indicate GAS5+Iba1+ cells.
Scale bars = 100 lm.
B A schematic map of the calculation of the ramification index (RI).
C Statistical analysis of the RI in Iba1+GAS5+ (n = 16) or Iba1+GAS5 (n = 17) cells.
D, E Representative FISH analysis of GAS5 (green) co-stained with an anti-TNF-a (D) or anti-Arg-1 (E) antibody (red) in spinal cord sections from EAE mice. Arrows
indicate GAS5+TNF-a+ cells in (D) and GAS5+Arg-1+ cells in (E). Scale bars = 25 lm.
F Statistical analysis of the proportion of GAS5+ cells in (D, E), n ≥ 3 experiments.
G A schematic map of the sorting of microglia in different phases of EAE and the control by FACS.
H Quantitative PCR analysis of GAS5 in different phases of EAE versus the control, n = 3 experiments.
Data information: *P < 0.05, ***P < 0.001 (C, Student’s t-test; H, one-way ANOVA with Dunnett’s post hoc test). Data are shown as the mean  SD.
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antibody against enhancer of zeste homolog 2 (EZH2), which is the
main catalytic subunit of PRC2. As shown in Fig 7A, a high propor-
tion of GAS5 was observed to bind with EZH2. The RNA pull-down
experiments confirmed the binding between GAS5 and EZH2 in
reverse (Fig 7B). RIP experiments with another antibody against
the main binding subunit of PRC2, RbAp48, showed a similar
phenomenon (Fig EV4C). In contrast, RIP experiments with an anti-
RING1A/B (subunits of PRC1) antibody showed no specific
◀ Figure 4. GAS5-modified microglia regulate the progression of EAE.A, B Clinical scores of EAE in mice transplanted with MGCtrlOE/MGGAS5OE (A) or MGCtrli/MGGAS5i (B) by lateral ventricle injection. CtrlOE, n = 18; GAS5OE, n = 18; Ctrli,
n = 8; GAS5i, n = 10 mice.
C, D Representative spinal cord sections from EAE mice at day 20 after immunization after H&E staining (C) and Luxol fast blue staining (D). Scale bars = 100 lm.
E, F Quantification of infiltration in the white matter (WM) (E) and the percentage of demyelinated WM in total WM (F) in (C and D), n ≥ 3 mice per group.
Data information: *P < 0.05, **P < 0.01, ***P < 0.001 versus control (A, B, Mann–Whitney U-test; E, F, Student’s t-test). Data are shown as the mean  SEM (A, B) or
mean  SD (E, F).
A D E
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Figure 5. Interfering with GAS5 in microglia attenuates EAE progression.
A Clinical scores of EAE in mice transplanted with MGCtrli/MGGAS5i by lateral ventricle injection, n = 6 mice per group.
B, C Representative spinal cord sections of H&E stained (B) and Luxol fast blue stained (C) EAE mice day 40 after immunization. Scale bars = 100 lm.
D, E Quantification of infiltration in the white matter (WM) (D) and the percentage of demyelinated WM in total WM (E) in (B and C), n = 3 mice per group.
Data information: *P < 0.05, **P < 0.01, ***P < 0.001 versus control (A, Mann–Whitney U-test; D, E, Student’s t-test). Data are shown as the mean  SEM (A) or
mean  SD (D, E).
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interaction (Fig EV4D). After knocking down EZH2 in microglia
(Appendix Fig S1B), the qPCR showed increased M2 markers and
decreased M1 markers, which further supported the notion that
PRC2 participates in the regulation of microglial polarization
(Fig 7C).
Next, we performed a ChIP assay to investigate whether the
interaction between EZH2 and the promoter areas of genes involved
in M2 polarization (i.e., PPARc, STAT6, IRF4, and C/EBPb) were
affected by GAS5 [22]. The results showed binding between EZH2
and the IRF4 promoter was significantly enhanced in the microglia
overexpressing GAS5 (Figs 7D and EV4E–G). ChIRP analysis further
confirmed the binding between GAS5 and the promoter regions of
IRF4 (Fig 7E), and ChIP using H3K27me3 antibody showed the
methylation of H3K27 at the IRF4 promoter was changed accord-
ingly (Fig 7F and G). Consistently, the qPCR and WB results
showed that IRF4 expression was decreased in MGGAS5OE (Fig 7H
and K) and increased in MGGAS5i (Fig 7I and L) and MGEZH2i (Fig 7J
and M). These results showed that GAS5 suppressed IRF4 transcrip-
tion by binding PRC2, thereby inhibiting microglial M2 polarization.
In addition, we analyzed another epigenetic histone mark by
performing ChIP assays using anti-H3K4me3 antibody. The results
show that H3K4me3 was decreased at the IRF4 promoter in
MGGAS5OE, but did not change in MGGAS5i (Appendix Fig S2), which
is in accordance with the inhibited transcription observed upon
GAS5 overexpression.
GAS5 inhibits human microglial M2 polarization and is
differentially expressed in MS lesions
LncRNAs usually lack conservatism among species, which limits the
universality of functions. However, GAS5 has a relatively high
homology between mice and humans. Therefore, we hypothesized
that human GAS5 may have similar functions. We constructed a
vector encoding human GAS5 and transfected human microglia
using electroporation. The qPCR showed that the M2 markers were
decreased and M1 markers were increased (Fig 8A). Following a
homo-transfer strategy to study the function of an lncRNA across
species [29], we transfected human GAS5 into mouse microglia
using electroporation; the qPCR showed an effect similar to mouse
GAS5 in microglial polarization (Fig 8B). These results showed that
the function of GAS5 in microglial polarization in humans and mice
was conserved.
We also examined the expression of GAS5 in microglia from MS
patients. Using brain tissues from MS patients kindly provided by
the Netherlands Brain Bank (NBB), we performed FISH and found
that more GAS5 was present in the amoeba-shaped microglia/
macrophages, which was in agreement with the finding from EAE
(Fig 8C). The ramification index of GAS5+ microglia/macrophages
was significantly higher than the index for GAS5 cells (Fig 8D).
These results strongly suggested that GAS5 might be involved in the
regulation of microglial functions in MS.
Discussion
From transcriptional “noise” to functional participants, the roles of
lncRNAs in neurological disorders are becoming recognized [15].
GAS5 is a functional lncRNA identified decades ago that has been
shown to be abnormally expressed in many types of tumors and to
inhibit T-cell proliferation [18,20]. In the present study, we demon-
strate a novel role for GAS5 in microglial polarization. As the local
macrophages, microglia are the major source of M2 cells in the CNS
◀ Figure 6. Interfering with GAS5 in microglia promotes remyelination in a LPC-induced focal lesion model.A Representative Luxol fast blue-stained dorsal column spinal cord sections from the MGCtrli/MGGAS5i groups at 7, 11, and 15 days post-LPC injection. Scale bar = 100 lm.
B Quantitative analysis of the demyelinated lesion volume 5 mm around the epicenter of (A), n = 3 mice per group.
C Representative anti-Olig2 (green) and anti-CC1 (red) immunohistofluorescence of dorsal column spinal cord sections from the MGCtrli/MGGAS5i groups at 7, 11, and
15 days post-LPC injection. Scale bar = 100 lm.
D, E Statistical analysis of Olig2+ (D) or CC1+ (E) cells of (C), n ≥ 3 mice per group.
F Representative electron micrographs of dorsal column spinal cord sections from the MGCtrli/MGGAS5i groups at 15 days post-LPC injection. Scale bar = 2 lm.
G Quantification analysis of myelinated axons among total axons between MGCtrli and MGGAS5i groups at 15 dpl, n = 3 mice per group.
H Statistical analysis of g-ratio between MGCtrli and MGGAS5i groups at 15 dpl.
I Analysis of the myelinated axons showed a reduction of the g-ratio in spinal cords in the MGGAS5i group (red) compared with the MGCtrli group (blue) at 15 dpl,
n = 3 mice per group.
Data information: **P < 0.01, ***P < 0.001 versus control (Student’s t-test). Data are shown as mean  SD.
▸Figure 7. GAS5 suppresses IRF4 transcription by binding PRC2 and inhibiting microglial M2 polarization.A RNA IP analysis of the binding between EZH2 and GAS5, n = 3 experiments.
B RNA pull-down analysis of the binding between EZH2 and GAS5.
C Quantitative PCR analysis of M1 and M2 markers in microglia transduced with the EZH2i lentivirus versus the control, n ≥ 4 experiments.
D ChIP analysis of microglia transduced with the CtrlOE or GAS5OE lentivirus. A relatively high enrichment was detected on the IRF4 promoter regions in MGGAS5OE
versus the control using the anti-EZH2 antibody, n = 3 experiments.
E ChIRP analysis of the binding between the IRF4 promoter and GAS5, n = 3 experiments. IGF1 served as a negative control.
F, G ChIP analysis of microglia transduced with the CtrlOE/GAS5OE (F) or Ctrli/GAS5i (G) lentivirus on the IRF4 promoter regions using the anti-H3K27me3 antibody,
n = 3 experiments.
H–J Quantitative PCR analysis of IRF4 in microglia transduced with the GAS5OE (H), GAS5i (I) or EZH2i (J) lentivirus, n ≥ 3 experiments per group.
K–M Western blotting analysis of IRF4 in microglia transduced with the GAS5OE (K), GAS5i (L), or EZH2i (M) lentivirus, n ≥ 3 experiments per group.
Data information: *P < 0.05, **P < 0.01, ***P < 0.001 versus control or IgG (A) (Student’s t-test). Data are shown as the mean  SD.
Source data are available online for this figure.
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[30]. The lack of M2 polarized microglia/macrophages impairs
remyelination in MS and other demyelinating diseases [9,10]. We
found that GAS5 modification in microglia affected the severity of
EAE. Interfering with GAS5 in microglia attenuated EAE progression
and promoted remyelination in a LPC model. Moreover, we found
that GAS5 exhibited higher expression in amoeba-shaped microglia/
macrophages in the brain slices of MS patients and mice with EAE.
We also demonstrated that the function of GAS5 in microglial polar-
ization was conserved in humans and mice. Our work suggested
that GAS5 was a promising target for the treatment of demyelinating
diseases such as MS.
Currently, little is known about GAS5 signaling, although GAS5
has been shown to act as a “decoy” to combine with the DNA-
binding domain of glucocorticoid receptor and block its interactions
A
C
B
D
Figure 8. GAS5 inhibits human microglial M2 polarization and is differentially expressed in MS lesions.
A Quantitative PCR analysis of M1 and M2 markers in human microglia nucleo-transfected with the human GAS5 plasmid versus the control, n ≥ 3 experiments.
B Quantitative PCR analysis of M1 and M2 markers in mouse microglia nucleo-transfected with the human GAS5 plasmid versus the control, n = 3 experiments.
C Representative FISH analysis of GAS5 (green) co-stained with the anti-Iba1 antibody (red) in brain slices from MS patients. Arrows indicate GAS5+Iba1+ cells. Scale
bar = 50 lm.
D Statistical analysis of the RI of Iba1+GAS5+ or Iba1+GAS5 cells in brain slices from MS patients, n = 6.
Data information: *P < 0.05, **P < 0.01, ***P < 0.001 (Student’s t-test). Data are shown as the mean  SD.
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with downstream targets [27]. However, GAS only interacts with
ligand-activated GR and only a very small portion of GAS5 binding
with GR at physiologic level of circulating cortisol, while no binding
exists without GR ligand. GAS5 was found regulating microglial
polarization under serum-free conditions, which indicates the role
of GR in the regulation of microglial polarization by GAS5 is ignor-
able. In the present study, we showed that GAS5 suppressed IRF4
transcription by binding with the major intracellular inhibitory
compound PRC2. IRF4 is one of the most important transcription
factors involved in microglial M2 polarization [22]. A previous
study showed that Jmjd3 increased IRF4 transcription by enhancing
the demethylation of histone 3 Lys27 in the IRF4 promoter region to
promote macrophage M2 polarization [31]. In this study, GAS5
interacted with PRC2 by binding with EZH2, which was the main
catalytic subunit of PRC2. Importantly, components of the polycomb
repressive complex 1 (PRC1) showed no interaction with GAS5,
supporting a specific role for PRC2 in recruiting lncRNAs. Further-
more, GAS5 overexpression enhanced the interaction between EZH2
and the IRF4 promoter and decreased IRF4 expression. Consistently,
interference with GAS5 or EZH2 in microglia increased IRF4 expres-
sion. These results suggest that GAS5 binds PRC2 to suppress IRF4
transcription and inhibit microglial M2 polarization. Further, the
active epigenetic mark H3K4me3 was reduced in MGGAS5OE at the
IRF4 promoter, but showed little changes in MGGAS5i, confirming the
reduced expression of IRF4 observed upon GAS5 overexpression, and
indicating that further regulative chromatin modifying mechanisms
act during this process.
In contrast to macrophage M1 polarization, the mechanism
underlying M2 polarization is not fully understood [22,32]. mTOR
activation has been shown to promote macrophage M2 polariza-
tion [23]. GAS5 is a member of the 50-terminal oligopyrimidine
tract (50-TOP) family that is controlled by mTOR and has been
shown to be upregulated by rapamycin (an mTOR inhibitor) in
prostate cancer and T cells [33,34]. Consistent with these reports,
we found that rapamycin treatment dramatically increased the
GAS5 level in microglia, suggesting that mTOR was upstream of
GAS5 in the regulation of microglial polarization. In the present
study, we also found that GAS5 expression was decreased after
IL-4 and M-CSF stimulation, both of which were reported to
promote M2 polarization. IL-4 promotes macrophage M2 polariza-
tion through PI3K and induces the expression of IRF4 [35,36],
whereas M-CSF can also activate PI3K and promote macrophage
M2 polarization by regulating IRF4 [22]. Because PI3K is upstream
of mTOR and GAS5 controls IRF4 expression [37], it is likely that
an IL-4/M-CSF-PI3K-mTOR-GAS5-IRF4 pathway exists. This
finding also explains why GAS5 expression decreased under IL-4
and M-CSF stimulation.
A further interesting point is that GAS5 is closely related to cell
proliferation [20]. We found that microglia from aged mice sorted
by flow cytometry showed higher GAS5 expression (Fig EV5A
and B). It is possible that this epigenetic regulation may account
for the obstacle in microglial M2 polarization and the relevant
failure in remyelination in aged mice [14,38]. Recently, Doring
et al [39] reported that promoting macrophage/microglial prolif-
eration with amphotericin B and M-CSF benefited remyelination.
It would be interesting to test whether GAS5 is involved in this
process as a more direct target that regulates the function of aged
microglia.
In summary, the data presented here demonstrated a novel role
for GAS5 in microglial polarization and the pathogenesis of demyeli-
nating diseases. These results suggest the potential therapeutic
benefit of targeting GAS5 for the treatment of neurological disorders
associated with microglial polarization, including MS, Alzheimer’s
disease, and Parkinson’s disease.
Materials and Methods
Animal experiments
The animal experiments in this study were performed in
adherence with the National Institutes of Health Guidelines on
the Care and Use of Laboratory Animals and were approved by
the Animal Experimentation Ethics Committee of the Second
Military Medical University. All animals were purchased from
Shanghai Slac Laboratory Animal Co., Ltd (Shanghai, China).
The detailed EAE induction methods were described previously
[13]. Briefly, female C57BL/6 mice (8–10 weeks of age) were
injected with MOG35–55 (GL Biochem, Shanghai) in complete
Freund’s adjuvant at 3 points in the back. The immunization
day was defined as day 0. Pertussis toxin (516561, Calbiochem-
EMD Chemicals) in PBS was administered intraperitoneally on
days 0 and 2. Clinical manifestations were examined daily by a
blinded observer.
For the lysolecithin model, spinal cord lesions were induced as
previously described [40]. Briefly, female C57BL/6 mice (6–8
weeks) were deeply anesthetized with 3% chloral hydrate and a
laminectomy was performed. After fixing the spine, 1 ll of 1%
lysolecithin (62962, Sigma-Aldrich) in a 0.9% sodium chloride
solution was injected into the dorsal funiculus at the level of the
T11–T12 vertebrae. The day of lysolecithin injection was desig-
nated day 0 (0 dpl). The spinal cord around the injection point
was isolated and cut into serial cryosections. The demyelinated
lesion volume 5 mm around the epicenter was calculated based
on the equation
V ¼
X
demyelinated lesion areawidth of section:
For transplantation of microglia in the EAE model, a small hole
was drilled into the mouse skull and 5 × 105 cells in 10 ll were
inserted into the right lateral ventricle with a microinjector. For
transplantation of microglia in the lysolecithin-induced focal lesion
model, 5 × 105 cells in 2 ll were injected in the area near the lysole-
cithin injection point using the above paradigm at 3 dpl. For both
models, microglia were injected at a flow rate of 1 ll/min, and all
injections were performed with a stereotaxic apparatus.
Cells cultures
Detailed methods for the primary culture and purification of microglia
and OPCs were previously described [13,41]. Briefly, P0 C57BL/6
mice were sacrificed to acquire mixed cerebrum glial cell cultures
containing microglia. After 10–14 days of growth in DMEM/F12
medium (Invitrogen) containing 10% fetal bovine serum (FBS, GBICO),
the cultures were shaken for 6 h at 180 rpm at 37°C to collect the
microglia. For M2 polarization, the microglia were stimulated with IL-4
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(10 ng/ml, R&D). To elucidate the role of mTOR in GAS5 expression,
the microglia were stimulated with rapamycin (20 nM, LC laborato-
ries). To obtain OPCs, P0 Sprague Dawley rats (SD rats) were sacrificed
to perform mixed cortical glial cell cultures. After 8–10 days of growth
in DMEM containing 10% FBS, the cultures were shaken for 1 h at
180 rpm at 37°C to remove the microglia. After replacing the medium,
the cultures were shaken for another 14 h at 200 rpm at 37°C to collect
the OPCs.
Primary cultured neurons were obtained from the cortices of P0
C57BL/6 mice as previously described [13]. After dissection and
digestion, the cortical neurons were suspended and seeded at a
density between 5,000 and 50,000 cells/cm2 onto poly-D-lysine-
coated coverslips. The medium was replaced with neurobasal
medium (GIBCO) supplemented with 2% B27 (GIBCO) after 4 h.
OPCs and neurons were co-cultured with microglia conditioned
media at a 1:1 ratio.
Primary human microglia (HM1900) were purchased from Scien-
Cell Research Laboratories (Carlsbad) and cultured in DMEM/F12
medium containing 10% FBS and 10 ng/ml macrophage–colony
stimulation factor (M-CSF, Sigma-Aldrich).
Microarray analysis
The microarray assay was performed using the Mouse LncRNA
Array V2.0 (Arraystar). Quantile normalization and subsequent data
processing were performed using the GeneSpring GX v11.5.1 soft-
ware package (Agilent Technologies). The threshold for differen-
tially expressed genes was fold change ≥ 2 and P-value ≤ 0.05.
Hierarchical clustering was performed using the TM-MEV software
(MultiExperiment Viewer).
The co-expression analysis was performed with the assistance of
Novel Bioinformatics Company. Briefly, the adjacency between two
genes was defined as a power of the Pearson correlation between
the corresponding gene expression profiles according to the normal-
ized signal intensity. When creating the visual representation, only
the strongest correlations (0.99 or greater) were drawn in these
renderings. In the gene co-expression networks, each gene corre-
sponds to a node, and two genes are connected by an edge (either
positive or negative). A degree is defined as the number of directly
linked neighbors. A k-core of a network or a graph is a subgraph in
which all nodes are connected to at least k other nodes in the
subgraph [42].
Lentivirus transduction and electroporation
The mouse GAS5 sequence (IMAGE clone 3585621, Thermo) was
ligated into the GV303 plasmid (GeneChem, Shanghai). The siRNAs
for mouse GAS5 or EZH2 were ligated into the GV113 plasmid
(GeneChem). The sequences for GAS5 siRNA were 50-GCGAGCG
CAATGTAAGCAA-30 and 50-CCTCTGTGATGGGACATCT-30, and the
sequences for EZH2 siRNA were 50-AAGCACAATGCAACACCAA-30
and 50-GCTTTGGACAACAAGCCTT-30. The titers of concentrated
viral particles ranged between 3 × 108 and 1 × 109 transducing
units/ml. Lentiviral particles were added to cultured microglia at a
multiplicity of infection (MOI) = 10, and the supernatant was
changed 12 h after infection.
The human GAS5 sequence was cloned and ligated into the
pCDH dual-promoter plasmid (CD513B-1, SBI). Mouse microglia
and human microglia were collected and transfected using nucleo-
fection (programs Y-001 and Y-010, respectively; Amaxa).
Flow cytometry
The isolation of microglia from EAE mice was performed as
previously described [13]. Briefly, EAE mice were sacrificed, and
the hindbrain and spinal cord were collected for homogenization
and digestion. After gradient centrifugation using Percoll
(17-0891-09, GE Healthcare), the majority of the mononuclear
cells were collected and stained with PE-CD45 (BD Biosciences)
and FITC-CD11b (BD Biosciences) antibodies after incubation
with a CD16/CD32 (BD Biosciences) antibody as a block.
CD11b+CD45L cells were sorted on a Moflo XDP (Beckman Coul-
ter) and assessed.
For apoptosis analysis, OPCs were stained with FITC-Annexin-V
and 7-AAD using a Cell Apoptosis Analysis Kit (Sungene, Tianjin)
according to the manufacturer’s instructions. Annexin-V+7-AAD
cells were considered cells in early apoptosis, whereas Annexin-
V+7-AAD+ cells were considered cells in late apoptosis.
RNA isolation and quantitative PCR
Total RNA was extracted with the TRIzol reagent (Invitrogen), and
first-strand cDNA was synthesized using a RevertAid First Strand
cDNA Synthesis Kit (Thermo Scientific Fermentas) according to the
manufacturer’s instructions. Quantitative PCR (qPCR) was
performed on a LightCycler 96 apparatus (Roche) using the SYBR
Green Real-time PCR Master Mix (TOYOBO). Gene expression was
normalized to a standard housekeeping gene (GAPDH) using the
DDCT method. Primers were listed in Appendix Tables S2 and S3.
Western blot and ELISA
Primary cell cultures were homogenized in NP40 buffer (Beyotime,
China) supplemented with a protease inhibitor cocktail (Roche).
The cell lysates were subjected to Western blotting using the anti-
IRF4 (1:500, sc-6059, Santa Cruz), anti-TNF-a (1:500, AF-510-NA,
R&D), anti-MBP (1:500, MAB382, Chemicon), anti-EZH2 (1:500,
ab3748, Abcam), and HRP-conjugated anti-GAPDH (Kangcheng,
Shanghai, China) antibodies. The protein bands were analyzed
using Image Lab analysis (Bio-Rad).
The TNF-a, IL-1b, and IGF-1 levels in the supernatants were
detected using an ELISA according to the manufacturer’s instruc-
tions (EK2822, EK201B2, Multi Sciences, Hangzhou, China; MG100,
R&D). The sample concentrations were calculated using an equa-
tion generated from a standard curve.
Fluorescence in situ hybridization (FISH) and
immunocytofluorescence staining (ICF)
An approximately 500-bp mouse or human GAS5 sequence
(Appendix Table S1) was cloned and ligated into the pEASY-T5 plas-
mid (Transgen, Beijing, China) containing the T3 and T7 promoters,
respectively. Antisense and sense digoxigenin-labeled cRNA probes
were synthesized with a DIG-RNA Labeling Kit (12430721, Roche)
with linearized templates. In situ hybridization was performed
according to the previous report [43].
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For ICF, cells or tissue sections were fixed, permeabilized, and
incubated with primary antibodies (MBP, MAB382, Chemicon;
MAP2, M9942, Sigma-Aldrich; TNF-a, AF-510-NA, R&D; Arg-1,
610708, BD; Olig2, AB9610, Millipore; CC1, ab16794, Abcam;
TMEM119, ab209064, Abcam; and Iba1, 019-19471, Wako) over-
night at 4°C, followed by 2 h of incubation with TRITC- or FITC-
conjugated secondary antibodies (Jackson Immuno Research).
Then, the samples were counterstained with Hoechst 33342 (Sigma-
Aldrich). Fluorescence images were captured using fluorescence
microscopy (DXM, Nikon) or confocal microscopy (Leica) and
analyzed using Image-Pro Plus (Media Cybernetics).
TUNEL assays
TUNEL assay was carried out using the In Situ Cell Death Detection
Kit, TMR red (12156, Roche) according to the manufacturer’s
instructions. Briefly, the specimens were fixed, permeabilized, and
subsequently incubated with the TUNEL reaction solution mixture
in a humidified 37°C chamber for 1 h. The cell nuclei were labeled
with Hoechst 33342. The percentage of TUNEL-labeled cells versus
Hoechst-labeled cells was calculated.
Histological staining
Lumbar spinal cords from EAE or lysolecithin-injected mice were
isolated and cut into cryosections or paraffin sections. Every 7th
(cryosection) or 15th (paraffin section) section was collected from each
animal. The sections were stained with hematoxylin and eosin (H&E)
solution or Luxol fast blue (LFB) and periodic acid schiff (PAS). The
inflammatory infiltrating cells for H&E and the demyelination area for
lysolecithin were calculated by blinded independent readers.
Transmission electron microscopy (EM)
Briefly, mice were sacrificed and transcardially perfused with 4%
PFA. Then, the dorsal column of spinal cords was isolated and fixed
in 2.5% glutaraldehyde for 2 h and post-fixed in 1% osmium tetrox-
ide for 45 min before being dehydrated and embedded in araldite
resin. Ultrathin sections (60 nm) were stained in uranyl acetate and
lead citrate. Samples were visualized using a transmission electron
microscope (Hitachi H-7650, Japan) at 100 KV.
RNA immunoprecipitation
The RNA immunoprecipitation (RIP) experiments were performed
using the Magna RIP RNA-Binding Protein Immunoprecipitation
Kit (17-700, Millipore) following the manufacturer’s instructions.
After incubation of the microglial lysate with the anti-EZH2
(ab3748, Abcam) or anti-GR (ab3580, Abcam) or anti-RbAp48
(ab1765, Abcam) or anti-RING1A/B (ab32644, Abcam) antibody,
the co-precipitated RNA was detected by qPCR. The ratio of RNA
binding with a specific antibody versus the total RNA was
calculated.
RNA pull-down
The RNA pull-down experiments were performed using the
Magnetic RNA-Protein Pull-Down Kit (20164, Thermo) following the
manufacturer’s instructions. The retrieved proteins were detected
by silver staining after SDS–PAGE gel electrophoresis or Western
blotting with an anti-EZH2 antibody (ab3748, Abcam).
ChIP and chromatin isolation by RNA purification (CHIRP)
ChIP was performed using an EZ ChIPTM Chromatin Immunoprecip-
itation Kit (17-371, Millipore) following the manufacturer’s proto-
col. Quantitative PCR was conducted to detect DNA fragments
binding with EZH2 or H3K27me3 (17-622, Millipore) or H3K4me3
(17-614, millipore). Primers were designed to detect a ~2,000-bp
area before the transcriptional start site. The ratio of DNA binding
with EZH2 versus total DNA was calculated and compared
between groups.
CHIRP was performed according to a previous report [44].
Briefly, biotin-labeled GAS5 cRNA probes as used in FISH were tran-
scribed with the Biotin RNA Labeling Mix (Roche) and T7 RNA
polymerase (Thermo) in vitro, treated with RNase-free DNase I
(Thermo), and purified with the RNA Purification Kit (Transgen).
Primary cultured microglia were collected and sonicated as in ChIP
with adding RNase inhibitors. Then, the hybridization was
performed with biotinylated cRNA probes at 60°C overnight in
hybridization solution. After adding streptavidin magnetic beads
(Roche) and incubating for 30 min at 37°C, beads were washed and
bound chromatin was isolated as in ChIP. Quantitative PCR was
conducted to detect DNA fragments binding with GAS5 and the ratio
of DNA binding with GAS5 versus total DNA was calculated.
Statistics
A two-tailed Student’s t-test was applied for the statistical compar-
ison of two groups, and a one-way ANOVA with Dunnett’s post hoc
test was used for multiple groups. The EAE model was analyzed
using the nonparametric Mann–Whitney U-test. The data were
presented as the mean  SD unless otherwise indicated. A P < 0.05
was considered statistically significant.
Data deposition
All microarray data have been deposited in the Gene Expression
Omnibus (GEO GSE99216).
Expanded View for this article is available online.
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